Boehringer Ingelheim
Health and innovation breakthroughs
- B2B
- Has physical offices
- Manufacturing
- Multi-product
- Sales-led purchase
About Boehringer Ingelheim
A company with over 56,000 employees focused on advancing health and innovation for humans and animals Join us in moving #LifeForward
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,000+ employees
- Headquarters
- Ingelheim am Rhein, Rhineland-Palatinate, Germany
- Revenue
- $847M – $6.7BTamtam estimate
- Website
- boehringer-ingelheim.com
Jobs at Boehringer Ingelheim
- Technicien Facility Management - Services Généraux (H/F) - CDI
- Global Facilities & Engineering Manager (MSI - Malaysia, Singapore, Indonesia)
- IT Co-Op Data Science
- Customer Service Officer
- Technicien métrologie (H/F) - CDI
- Animal Health Asesor/a de Negocios Ventas (CDMX)
- Director, Capability Team Lead
- Gerente Ejecutivo de Mercado de Salud y Paciente México & Centroamérica y Caribe
Boehringer Ingelheim in the news
- Boehringer, Zealand obesity drug face tolerability questions after Phase 3 success
Boehringer Ingelheim's survodutide showed promising weight loss and blood sugar control in a Phase 3 trial but faced high discontinuation rates due to gastrointestinal side effects.
- Boehringer-Familie erstmals an der Spitze der Reichstenliste
The Boehringer family, owners of Boehringer Ingelheim, leads Germany's wealthiest list for the first time with 66.7 billion euros.
- Zealand dips as Boehringer Ingelheim-partnered weight loss drug fails to impress—again
A weight loss drug developed by Zealand Pharma and Boehringer Ingelheim delivered underwhelming results in a second Phase 3 trial, leading to a dip in Zealand's stock.
- Boehringer Familie zieht an Lidl Gründer Dieter Schwarz vorbei
The Boehringer Ingelheim family has overtaken Dieter Schwarz as the wealthiest in Germany, with their estimated 66.7 billion Euro fortune topping the 2026 rich list due to a change in ranking methodology, even as Schwarz's wealth also increased.
- Boehringer, Zealand Obesity Drug’s Weight Loss Disappoints
Boehringer Ingelheim and Zealand Pharma's experimental obesity drug survodutide demonstrated a 13.1% weight loss in diabetic patients, but the results disappointed investors.
Boehringer Ingelheim at a glance
Boehringer Ingelheim is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Ingelheim am Rhein, Rhineland-Palatinate, Germany.
Boehringer Ingelheim has 10,000+ employees.
Boehringer Ingelheim's revenue is $847M – $6.7B (Tamtam estimate).
Boehringer Ingelheim is hiring: 8 recent open roles, including Technicien Facility Management - Services Généraux (H/F) - CDI, Global Facilities & Engineering Manager (MSI - Malaysia, Singapore, Indonesia), IT Co-Op Data Science.
Selling to companies like Boehringer Ingelheim?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies